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Synthesis of Tetrahydro-1,2-oxazines and Pyrrolidines  via 
Cycloadditions of Donor-Acceptor Cyclobutanes and 
Nitrosoarenes 
Naresh Vemula[a] and Brian L. Pagenkopf*[a] 
Keywords: Donor-Acceptor Cyclobutanes / Cycloadditions / Nitrosoarenes / Lewis Acid Catalysis / Tetrahydro-1,2-oxazines / 
Pyrrolidines 
During efforts to expand the scope of Lewis acid catalyzed [4+2] 
cycloaddition between donor-acceptor cyclobutanes and 
nitrosoarenes, an unexpected formation of pyrrolidine products was 
discovered when 50 mol % of MgI2 was used as a Lewis acid. It was 
also observed that the electronics of the nitrosoarene and judicious 
selection of the Lewis acid catalyst have a profound effect on the 
regioselectivity of the reaction. 
 
Introduction 
 
Cycloaddition chemistry is an excellent method to construct 
highly complex structures from simple starting materials. [ 1 ] In 
particular, 1,3-dipolar cycloadditions using a variety of dipolarophiles 
have been extensively studied and well documented. [2] Interestingly, 
generation of 1,4-dipolar intermediates by exploitation of ring strain in 
carbocycles is a clever approach in modern organic synthesis.[3] In 
this regard, reactivity of donor-acceptor (DA) cyclobutanes has 
recently garnered significant attention, and a number of reactive 
partners have been found to undergo cycloadditions with DA 
cyclobutanes[4] and cyclobutanones.[5] 
Recently, we reported the first examples of [4+2] cycloadditions 
between DA cyclobutanes and nitrosoarenes (Scheme 1).[ 6 ] The 
reactions proceed well with electron-neutral and electron-deficient 
nitrosoarenes to form tetrahydro-1,2-oxazines with excellent 
regioselectivity; however, no reaction was observed with electron-rich 
nitrosoarenes under the reported conditions.  
 
Scheme 1. Previous work with DA cyclobutanes and nitrosoarenes. 
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Results & Discussion 
 
In an attempt to extend the reaction scope to include electron-
rich substrates, we employed 1-methoxy-4-nitrosobenzene 2a as a 
model substrate. After a thorough screening of Lewis acids under a 
variety of conditions, MgI2 was found to be functional for this reaction, 
however producing low yields of product (Scheme 2).[7] Interestingly 
the regioisomer isolated under these conditions was acetal 4a and not 
the aminal 3a as expected (compare schemes 1 and 2).  
 
 
Scheme 2. Reaction of DA cyclobutane 1a with 2a under MgI2 catalysis. 
 
Scheme 3. Proposed mechanism for the formation of 4a. 
 
This reversal in regioselectivity could be rationalized by the 
proposed mechanism (Scheme 3). The electron donating methoxy 
group on the aryl ring enhances the nucleophilicity of the nitroso 
oxygen, causing the oxygen to act as the nucleophile instead of 
nitrogen. Nucleophilic addition of the oxygen of the nitroso on the 
oxocarbenium ion A followed by cyclization via intermediate  B would 
yield 4a. 
During the optimization of this reaction an interesting 
observation was made.[8] When the reaction was left to stir for 2 days 
at room temperature or when 4a was treated with 50 mol % MgI2 at 
room temperature overnight, pyrrolidine 5a was formed with trace 
amounts of lactone 6a (Scheme 4). 
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Scheme 4. Formation of pyrrolidine 5a. 
 
Scheme 5. Proposed mechanism for the formation of 5a and 6a. 
A postulated mechanism to explain this unique redox 
transformation is depicted in Scheme 5. Coordination of MgI2 to the 
oxygen of tetrahydro-1,2-oxazine 4a polarizes both the C-O and N-O 
bonds indicated. Cleavage of the C-O bond (Path A) generates an 
oxocarbenium ion C, which then undergoes nucleophilic attack by the 
pendant nitrogen, forming pyrrolidinium intermediate D.  Finally, the 
initially displaced iodide reacts with the Mg side chain on the nitrogen, 
resulting in N-O bond reduction, and concomitantly producing I2, MgO, 
and pyrrolidine 5a. Lactone 6a can be formed via N-O bond cleavage 
of 4a (Path B) leading to intermediate E followed by internal hydride 
migration. 
Based on the proposed mechanism it is clear that stoichiometric 
MgI2 was necessary for complete conversion of 4a to 5a, but 
disappointingly the yields were further lowered with considerable 
decomposition of cyclobutane under such conditions.  
With these interesting results we proceeded to investigate if 
other nitrosoarenes would follow a similar reaction manifold under 
MgI2 promoted conditions. Thus, the reaction of electron-rich 
nitrosoarene 2b (which did not react under 10 or 20 mol % MgI2 
loadings) directly yielded pyrrolidine 5b (entry 2, Table 1), and 
isolation of the anticipated tetrahydro-1,2-oxazine 4b was not possible. 
 
 
Table 1. Scope of the MgI2 promoted cycloaddition. 
 
Entry Nitrosoarene Product MgI2 
(mol %) 
Yield 
(%)[b] 
1 2a Ar = 4-C6H4OMe 5a 50 26 
2 2b Ar = 4-C6H4N(CH3)2 5b 50 22 
3 2c Ar = 4-C6H4CN 4c, 7c (2:1)[a] 10 35 
4 2d Ar = C6H5 3d 10 56 
5 2e Ar = 2-pyridine 4e 50 28 
6 2f Ar = N-BOC-5-nitrosoindole 4f 10 19 
[a] Ratio of 4:7 of isolated overall yields. [b] Isolated yields. 
 
Interestingly, the substrate 2c, which afforded aminal 3c as the 
major product under Yb(OTf)3 catalysis (Scheme 1), resulted in 
reversal of regioselectivity albeit in low yield (entry 3, Table 1). Also, 
the isolated aminal 7c was the trans-diastereomer (confirmed by 
single-crystal X-ray diffraction),[9] rather than cis (3c, Scheme 1).[10] 
Nitrosobenzene 2d, which is electronically sandwiched between 2a 
and 2c, produced aminal 3d as the exclusive product. The hetero-
nitrosoarenes 2-nitrosopyridine 2e and BOC protected 5-nitrosoindole 
2f, which did not react under Yb(OTf)3 conditions, provided exclusive 
acetal products (4e and 4f respectively) in low yields (entries 5 and 6, 
Table 1). 
Next other cyclobutanes were explored under both Yb(OTf)3 
and MgI2 reaction conditions (Table 2). The DA cyclobutane 1b gave 
a moderate yield with nitrosobenzene 2d under Yb(OTf)3 catalysis, 
while electron-rich nitrosoarenes 2a and 2b resulted in low yields of 
exclusive pyrrolidine products 9a and 9b respectively (entries 2 and 
3, Table 2). Crystals of 9a were obtained and the X-ray structure 
unambiguously establishes the pyrrolidine product (Figure 1).[11] 
 
Figure 1. ORTEP structure of 9a. 
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Table 2. Reaction scope of DA cyclobutanes in the cycloaddition. 
 
 
Entry Cyclobutane Nitrosoarene 
Product Yield[a] 
Yb(OTf)3 MgI2 
1 
 
2d Ar = C6H5 
2a Ar = 4-C6H4OMe 
2b Ar = 4-C6H4N(CH3)2 
AM-8d, 45% 
- 
- 
- 
Pyr-9a, 35% 
Pyr-9b, 18% 
2 
3 
4 
 
2d Ar = C6H5 
2g Ar = 4-C6H4Cl 
AM-10d, 73% 
AM-10g, 70% 
- 
- 5 
6 
 
2d Ar = C6H5 
2a Ar = 4-C6H4OMe 
AM-11d, 21% 
- 
- 
AC-12a, 38% 7 
[a] Isolated yield. 
The DA cyclobutane 1c smoothly reacted with nitrosobenzene 
2d and 1-chloro-4-nitrosobenzene 2h to furnish tetrahydro-1,2-
oxazines 10d and 10g in good yields (entries 4 and 5, Table 2). 
Disappointingly the ethoxy substituted DA cyclobutane 1d gave a poor 
yield with nitrosobenzene 2d, while electron-rich nitrosoarene 2a 
resulted in a low yield of acetal product 12a (entry 7, Table 2). 
Knowing that the acetal 4a could be converted into pyrrolidine 
5a via MgI2 mediated reaction (Scheme 4), 12a was subjected 50 
mol % of MgI2 in CH2Cl2 (Scheme 6). However, the reaction yielded 
ester 14a instead of pyrrolidine 13a. 
 
Scheme 6. Reaction of 12a under MgI2 conditions. 
 
 
 
 
 
Conclusions 
In conclusion, we have discovered the formation of unexpected 
pyrrolidine products in MgI2 promoted cycloaddition reactions 
between DA cyclobutanes and electron-rich nitrosoarenes. The scope 
of Yb(OTf)3 catalyzed [4+2] cycloaddition between DA cyclobutanes 
and nitrosoarenes is extended to additional DA cyclobutanes. 
Furthermore a procedure to make pyrrolidines from tetrahydro-1,2-
oxazines was reported. The regiochemistry and stereochemistry of 
the unexpected pyrrolidine product 9a has been unambiguously 
assigned by single-crystal X-ray diffraction. Future work includes 
mechanistic studies to further efficiency of the process. 
Experimental Section 
General experimental details: 
All reactions were run under argon atmosphere unless otherwise 
indicated. Flasks were oven dried and cooled in a desiccator prior to use. 
Solvents and reagents were purified by standard methods.[ 12 ] 
Dichloromethane was purified by passing the solvent through an activated 
alumina column. All other chemicals were of reagent quality and used as 
obtained from commercial sources unless otherwise noted. The progress 
of reactions were monitored by thin layer chromatography (TLC) 
performed on F254 silica gel plates. The plates were visualized by UV light 
(254 nm) or by staining with ceric ammonium molybdate (CAM).[13] Column 
chromatography was performed with Silica Flash P60 60 Å silica gel from 
SiliCycle® according to the Still method.[14] 
The 1H and 13C NMR data were obtained on either 400 or 600 MHz 
spectrometers. All spectra were obtained in deuterated chloroform and 
were referenced to the residual chloroform at 7.26 ppm for 1H spectra and 
the center peak of the triplet at 77.0 ppm for 13C spectra. When peak 
multiplicities are given, the following abbreviations are used: s, singlet; d, 
doublet; dd, doublet of doublets; ddd, doublet of doublet of doublets; t, 
triplet; q, quartet; quin, quintet; dt, doublet of triplets; dq, doublet of 
quartets; m, multiplet; br, broad; app, apparent. Scalar coupling was 
eliminated from nOe experiments by using acquisition delays of 500 ms. 
Electron ionization mass spectra were obtained on a Finnigan MAT 8200 
spectrometer at an ionizing voltage of 70 eV. 
Nitrosoarenes, which are not commercially available, were prepared 
according to literature methods.[15] 
Table 1. Catalyst screening for electron-rich nitrosoarenes. 
entry[a] catalyst 
mol 
% 
temperature, time result[b] 
1 Yb(OTf)3 50 rt, 30 min 19 %[c] 
2 Zn(OTf)2 10 rt, 20 h 13%[c] 
3 ZnCl2 10 rt, 6 h 26%[c] 
4 Zn(NTf2)2 10 rt, 2 h 4a-15% 
5 AlCl3 10 rt, 23 h 4a-9% 
6 AlBr3 10 rt, 72 h no reaction[f] 
7 AlMe3 20 rt, 24 h no reaction[f] 
8 MADNTf2 100 rt, 72 h no reaction[f] 
9 Et2AlCl 20 0 °C, 2 h; rt, 18 h decomposition[e] 
10 Sc(OTf)3 10 rt, 30 min decomposition[e] 
11 CuI 10 rt, 52 h no reaction[f] 
12 Cu(OTf)2 10 rt, 30 min 4a-14%  
13 SnCl2 10 rt, 46 h no reaction[f] 
14 SnCl4 10 0 °C, 1 h decomposition[e] 
15 Sn(OTf)2 10 rt, 18 h 4a-10%  
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16 Bu2BOTf 10 0 °C, 2 h; rt, 30 min decomposition[e] 
17 BF3∙OEt2 10 0 °C, 4 h; rt, 18 h decomposition[e] 
18 AgOTf 10 rt, 15 min decomposition[e] 
19 AgCl 10 rt, 18 h decomposition[e] 
20 ZrCl4 10 0 °C, 3 h; rt, 18 h decomposition[e] 
21 TiCl4 10 0 °C, 3 h; rt, 18 h decomposition[e] 
22 In(NTf2)3 10 rt, 30 min 4a-20% 
23 In(OTf)3 10 rt, 3.5 h 4a-13% 
24 MgCl2 10 rt, 100 h no reaction[f] 
25 MgBr2 10 rt, 120 h 4a-4% 
26 Mg(ClO4)2 10 0 °C, 4 h; rt, 2 h decomposition[e] 
27 MgI2 10 rt, 23 h 4a-20% 
28 MgI2 5 rt, 24 h 4a-17% 
29 MgI2 10 0 °C, 40 h 4a-30% 
30 MgI2 10 -20 °C, 72 h 4a-20% 
31 MgI2 50 0 °C, 15 min 4a-26% 
32 MgI2 50 rt, 18 h 
4a-13%,5a-
13%[g] 
33 MgI2 50 rt, 48 h 5a-22%[g] 
34 MgI2 10 
40 °C, 45 min[d]; 
100 °C, 30 min[d] 
4a-9%, 5a-
11%[g] 
[a] Typical reaction conditions: To a solution of Lewis acid  in CH2Cl2 (3 mL) at 
specified temperature, was added nitrosoarene 2a (0.3 mmol) followed by 
cyclobutane 1a (0.36 mmol). Reactions were monitored until nitrosoarene 2a 
was consumed by TLC. [b] Isolated yields. [c] 1:1 mixture 4a and another unknown 
compound by 1H NMR. [d] Microwave irradiation. [e] Cyclobutane 1a consumed.  
[f] Cyclobutane 1a recovered with some decomposition based on TLC and/or 
crude NMR. [g]Trace amount of 6a was also isolated. 
 
General Yb(OTf)3 catalyzed cycloaddition procedure 
To a stirred solution of Yb(OTf)3 (4 mg, 0.006 mmol, 2 mol %) in CH2Cl2 (3 
mL) at room temperature was added nitrosoarene (0.30 mmol, 1.0 equiv) 
followed by cyclobutane (0.36 mmol, 1.2 equiv). After complete 
consumption of the nitrosoarene (as indicated by TLC) the reaction mixture 
was layered directly onto a silica gel column and purified by flash 
chromatography (0-25% EtOAc/hexanes). 
General MgI2 catalyzed cycloaddition procedure 
To a stirred solution of MgI2 (41.5 mg, 0.15 mmol, 50 mol %) in CH2Cl2 (3 
mL) at 0 °C was added nitrosoarene (0.30 mmol, 1.0 equiv) followed by 
cyclobutane (0.36 mmol, 1.2 equiv). After complete consumption of the 
nitrosoarene (as indicated by TLC) the reaction mixture was layered 
directly onto a silica gel column and purified by flash chromatography (0-
25% EtOAc/hexanes). 
Compound 4a: The title compound was prepared according to the general 
MgI2 catalyzed cycloaddition procedure at 0 °C for 15 minutes to afford a 
pale yellow paste (30 mg, 26%); Rf 0.41 (1:1 hexanes /EtOAc); 1H NMR 
(600 MHz, CDCl3) δ 7.24 – 7.26 (m, 2 H), 6.75 – 6.77 (m, 2 H), 5.55 (d, J 
= 5.3 Hz, 1 H), 4.20 – 4.24 (m, 1 H), 4.15 – 4.19 (m, 1 H), 4.07 – 4.13 (m, 
2 H), 4.01 – 4.06 (m, 1 H), 3.96 (td, J = 8.1, 5.0 Hz, 1 H), 3.76 (s, 3 H), 
2.61 – 2.72 (m, 2 H), 2.50 – 2.57 (m, 1 H), 2.01 – 2.09 (m, 1 H), 1.95 (dq, 
J = 12.2, 6.3 Hz, 1 H), 1.14 (t, J = 7.0 Hz, 3 H), 1.10 (t, J = 7.0 Hz, 3 H); 
13C NMR (101 MHz, CDCl3) δ 169.0, 168.8, 156.6, 140.7, 122.7, 113.0, 
104.5, 74.3, 68.8, 61.9, 61.6, 55.4, 35.1, 32.3, 28.9, 13.8, 13.8; HRMS m/z 
379.1635 (calcd for C19H25NO7, 379.1631). 
Compound 5a: To a stirred solution of MgI2 (44 mg, 0.16 mmol) in 10 mL 
CH2Cl2 at room temperature was added 4a (120 mg, 0.32 mmol). The 
reaction mixture was stirred for about 18 hours at room temperature 
(complete consumption of starting material by TLC) then the reaction 
mixture was layered directly onto a silica gel column and purified by flash 
chromatography (0-25% EtOAc/hexanes); Rf 0.37 (1:1 hexanes /EtOAc); 
1H NMR (600 MHz, CDCl3) δ 6.90 – 6.94 (m, 2 H), 6.75 – 6.78 (m, 2 H), 
5.62 (d, J = 5.9 Hz, 1 H), 4.15 – 4.25 (m, 4 H), 3.91 – 4.00 (m, 2 H), 3.74 
(s, 3 H), 3.00 – 3.07 (m, 1 H), 2.70 (dd, J = 12.9, 8.8 Hz, 1 H), 2.39 (dd, J 
= 13.5, 8.8 Hz, 1 H), 2.00 – 2.08 (m, 1 H), 1.72 (dd, J = 12.6, 5.0 Hz, 1 H), 
1.21 (t, J = 7.3 Hz, 3 H), 1.18 (t, J = 7.3 Hz, 3 H); 13C NMR (101 MHz, 
CDCl3) δ 170.7, 169.9, 153.4, 138.3, 117.6, 113.9, 98.6, 74.8, 65.5, 61.8, 
61.8, 55.5, 40.6, 40.1, 32.0, 14.0, 14.0; HRMS m/z 363.1692 (calcd for 
C19H25NO6, 363.1682). 
Compound 6a: The title compound was isolated in trace amount along 
with 5a as pale brown oil; Rf 0.24 (70% hexanes /EtOAc); 1H NMR (600 
MHz, CDCl3) δ 6.75 – 6.72 (m, 2 H), 6.65 – 6.62 (m, 2 H), 4.89 (s, 1 H), 
4.29 – 4.15 (m, 5 H), 4.06 (ddd, J = 11.2, 9.1, 6.2 Hz, 1 H), 3.72 (s, 3 H), 
3.09 (dd, J = 15.3, 3.5 Hz, 1 H), 2.67 – 2.60 (m, 1 H), 2.44 (dd, J = 15.3, 
10.0 Hz, 1 H), 2.34 – 2.27 (m, 1 H), 1.78 (qd, J = 11.7, 8.8 Hz, 1 H), 1.21 
– 1.16 (m, 6 H); 13C NMR (101 MHz, CDCl3) δ 178.8, 169.9, 169.2, 153.3, 
137.5, 116.9, 114.7, 67.9, 66.4, 62.5, 62.5, 55.5, 35.2, 33.7, 29.7, 13.9; 
HRMS m/z 379.1639 (calcd for C19H25NO7, 379.1631). 
Compound 5b: The title compound was prepared according to the general 
MgI2 catalyzed cycloaddition procedure at room temperature for 4 hours to 
afford a yellow colored oil (25 mg, 22%); Rf 0.33 (60% hexanes /EtOAc); 
1H NMR (600 MHz, CDCl3) δ 6.90 – 6.94 (m, 2 H), 6.66 – 6.70 (m, 2 H), 
5.62 (d, J = 5.9 Hz, 1 H), 4.13 – 4.24 (m, 4 H), 3.91 – 3.98 (m, 2 H), 2.99 
– 3.06 (m, 1 H), 2.82 (s, 6 H), 2.68 (dd, J = 13.5, 8.8 Hz, 1 H), 2.37 (dd, J 
= 13.2, 8.5 Hz, 1 H), 1.98 – 2.06 (m, 1 H), 1.70 (dd, J = 12.6, 4.4 Hz, 1 H), 
1.15 – 1.21 (m, 6 H); 13C NMR (101 MHz, CDCl3) δ 170.9, 170.0, 145.3, 
136.0, 118.2, 114.3, 98.7, 74.8, 65.4, 61.7, 61.6, 41.7, 40.5, 40.0, 32.2, 
14.0, 14.0; HRMS m/z 376.2044 (calcd for C20H28N2O5, 376.1998). 
Compound 7c:[9] The title compound was prepared along with 4c 
according to the general MgI2 (10 mol %) catalyzed cycloaddition 
procedure at room temperature for 2 hours to afford a pale brown solid (15 
mg, 13%); Rf 0.44 (70% hexanes /EtOAc); 1H NMR (600 MHz, CDCl3) δ 
7.60 – 7.63 (m, 2 H), 7.54 – 7.59 (m, 2 H), 4.22 – 4.34 (m, 5 H), 4.06 – 
4.15 (m, 2 H), 2.98 (dd, J = 12.9, 3.5 Hz, 1 H), 2.24 – 2.32 (m, 1 H), 2.19 
– 2.24 (m, 1 H), 1.87 (t, J = 12.9 Hz, 1 H), 1.70 – 1.79  (m, 1 H), 1.30 (t, J 
= 7.0 Hz, 3 H), 1.24 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, CDCl3) δ 
167.0, 166.2, 151.9, 132.5, 119.4, 119.2, 107.2, 94.5, 84.0, 67.7, 62.6, 
62.3, 41.4, 34.1, 27.9, 14.0, 14.0; HRMS m/z 374.1480 (calcd for 
C19H22N2O6, 374.1478). 
Compound 4e: The title compound was prepared according to the general 
MgI2 catalyzed cycloaddition procedure at room temperature for 2 hours to 
afford a yellow syrup (30 mg, 28%); Rf 0.34 (70% hexanes /EtOAc); 1H 
NMR (600 MHz, CDCl3) δ 8.01 – 8.04 (m, 1 H), 7.55 – 7.60 (m, 1 H), 7.19 
– 7.23 (m, 1 H), 6.75 – 6.79 (m, 1 H), 5.58 (d, J = 4.7 Hz, 1 H), 4.22 – 4.32 
(m, 2 H), 4.19 (q, J = 7.0 Hz, 1 H), 4.10 – 4.17 (m, 1 H), 3.93 (q, J = 8.0 
Hz, 1 H), 2.68 – 2.77 (m, 2 H), 2.53 – 2.60 (m, 1 H), 1.98 – 2.10 (m, 2 H), 
1.22 – 1.27 (m, 3 H), 1.13 – 1.17 (m, 3 H); 13C NMR (101 MHz, CDCl3) δ 
168.9, 168.7, 159.3, 145.6, 137.5, 116.7, 109.8, 104.1, 69.9, 69.1, 62.0, 
61.6, 36.1, 31.8, 27.6, 13.8, 13.7; HRMS m/z 350.1470 (calcd for 
C17H22N2O6, 350.1478). 
Compound 4f: The title compound was prepared according to the general 
MgI2 (10 mol %) catalyzed cycloaddition procedure at room temperature 
for 4 hours to afford a pale yellow oil (28 mg, 19%); Rf 0.29 (70% hexanes 
/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.94 (d, J = 8.6 Hz, 1 H), 7.52 (d, J 
= 3.5 Hz, 1 H), 7.50 (d, J = 2.3 Hz, 1 H), 7.26 (dd, J = 9.0, 2.3 Hz, 1 H), 
6.47 (d, J = 3.5 Hz, 1 H), 5.60 (d, J = 5.5 Hz, 1 H), 3.94 – 4.28 (m, 6 H), 
2.64 – 2.77 (m, 2 H), 2.51 – 2.62 (m, 1 H), 2.02 – 2.13 (m, 1 H), 1.92 – 
2.02 (m, 1 H), 1.65 (s, 9 H), 1.12 (t, J = 7.0 Hz, 3 H), 1.04 (t, J = 7.0 Hz, 3 
H); 13C NMR (101 MHz, CDCl3) δ 169.0, 168.9, 142.9, 130.1, 126.1, 118.0, 
114.1, 112.9, 107.5, 104.5, 83.4, 74.4, 68.8, 62.0, 61.6, 35.3, 32.6, 29.0, 
28.2, 13.8, 13.7; HRMS m/z 488.2153 (calcd for C25H32N2O8, 488.2159). 
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Compound 8d: The title compound was prepared according to the general 
Yb(OTf)3 catalyzed cycloaddition procedure for 4 hours to afford a pale 
yellow solid (50 mg, 45%); Rf 0.25 (70% hexanes /EtOAc); 1H NMR (600 
MHz, CDCl3) δ 7.22 – 7.31 (m, 4 H), 7.00 (t, J = 7.0 Hz, 1 H), 4.88 (d, J = 
2.9 Hz, 1 H), 4.26 – 4.33 (m, 2 H), 4.14 – 4.26 (m, 2 H), 4.04 – 4.10 (m, 1 
H), 3.50 (td, J = 11.7, 1.8 Hz, 1 H), 2.42 – 2.49 (m, 1 H), 2.22 – 2.35 (m, 2 
H), 1.87 – 1.95 (m, 1 H), 1.76 – 1.86 (m, 2 H), 1.31 (t, J = 7.0 Hz, 3 H), 
1.16 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, CDCl3) δ 168.0, 166.9, 146.6, 
128.5, 122.9, 117.4, 84.4, 67.9, 62.1, 61.8, 29.9, 28.5, 27.5, 20.1, 14.1, 
14.0; HRMS m/z 363.1688 (calcd for C19H25NO6, 363.1682). 
Compound 9a:[11] The title compound was prepared according to the 
general MgI2 catalyzed cycloaddition procedure at 0 °C for 15 minutes to 
afford a pale brown solid (40 mg, 35%); Rf 0.26 (70% hexanes /EtOAc); 1H 
NMR (600 MHz, CDCl3) δ 6.90 – 6.94 (m, 2 H), 6.72 – 6.77 (m, 2 H), 5.03 
(d, J = 3.5 Hz, 1 H), 4.15 – 4.25 (m, 4 H), 3.90 – 3.96 (m, 1 H), 3.73 (s, 3 
H), 3.44 (td, J = 11.3, 2.1 Hz, 1 H), 2.84 (t, J = 12.3 Hz, 1 H), 2.43 (dd, J = 
12.0, 6.8 Hz, 1 H), 2.33 – 2.40 (m, 1 H), 1.85 – 1.94 (m, 1 H), 1.69 – 1.80 
(m, 2 H), 1.38 – 1.44 (m, 1 H), 1.22 (t, J = 7.0 Hz, 3 H), 1.16 (t, J = 7.0 Hz, 
3 H); 13C NMR (101 MHz, CDCl3) δ 171.1, 153.3, 137.8, 118.0, 113.8, 90.0, 
74.0, 63.9, 61.7, 61.7, 55.5, 38.2, 35.1, 23.7, 20.7, 14.0, 13.9; HRMS m/z 
377.1837 (calcd for C20H27NO6, 377.1838). 
Compound 9b: The title compound was prepared according to the general 
MgI2 catalyzed cycloaddition procedure at 0 °C for 1 hour, followed by 1 
hour at room temperature to afford a yellow oil (22 mg, 19%); Rf 0.43 (50% 
hexanes /EtOAc); 1H NMR (600 MHz, CDCl3) δ 6.92 – 6.96 (m, 2 H), 6.65 
– 6.68 (m, 2 H), 5.01 (d, J = 4.1 Hz, 1 H), 4.15 – 4.21 (m, 4 H), 3.92 (d, J 
= 11.2 Hz, 1 H), 3.42 (td, J = 11.0, 2.1 Hz, 1 H), 2.82 (s, 6 H), 2.39 – 2.44 
(m, 1 H), 2.33 – 2.39 (m, 1 H), 1.83 – 1.93 (m, 1 H), 1.68 – 1.80 (m, 2 H), 
1.37 – 1.43 (m, 1 H), 1.24 – 1.30 (m, 1 H), 1.21 (t, J = 7.3 Hz, 3 H), 1.15 (t, 
J = 7.0 Hz, 3 H); 13C NMR (101 MHz, CDCl3) δ 171.4, 170.4, 145.5, 135.5, 
118.9, 114.3, 90.2, 74.1, 63.8, 61.6, 61.5, 41.8, 38.1, 35.2, 23.8, 20.8, 14.0, 
13.9; HRMS m/z 390.2167 (calcd for C21H30N2O5, 390.2155). 
Compound 10d: The title compound was prepared according to the 
general Yb(OTf)3 catalyzed cycloaddition procedure for 15 minutes to 
afford a pale yellow oil (85 mg, 73%); Rf 0.59 (70% hexanes /EtOAc); 1H 
NMR (600 MHz, CDCl3) δ 7.18 - 7.24 (m, 4 H), 6.98 - 7.01 (m, 1 H), 4.11 - 
4.22 (m, 4 H), 3.13 (s, 3 H), 2.60 (t, J = 12.6 Hz, 1 H), 2.14 (dd, J = 12.6, 
3.8 Hz, 1 H), 1.95 - 2.00 (m, 1 H), 1.66 - 1.75 (m, 2 H ), 1.60 - 1.65 (m, 1 
H), 1.43 - 1.48 (m, 2 H), 1.21 - 1.35 (m, 3 H), 1.12 - 1.18 (m, 6 H); 13C NMR 
(101 MHz, CDCl3) δ 168.8, 167.9, 148.8, 127.6, 123.3, 120.5, 101.4, 76.3, 
62.1, 61.0, 48.1, 40.6, 33.8, 29.3, 27.6, 25.5, 22.5, 13.9, 13.7; HRMS m/z 
391.1987 (calcd for C21H29NO6, 391.1995). 
Compound 10g: The title compound was prepared according to the 
general Yb(OTf)3 catalyzed cycloaddition procedure for 45 minutes to 
afford a pale yellow oil (90 mg, 70%); Rf 0.65 (70% hexanes /EtOAc); 1H 
NMR (600 MHz, CDCl3) δ 7.16 (s, 4 H), 4.11 - 4.23 (m, 4 H), 3.10 (s, 3 H), 
2.58 (t, J = 12.6 Hz, 1 H), 2.12 (dd, J = 12.6, 3.8 Hz), 1.93 – 1.99 (m, 1 H), 
1.60 - 1.75 (m, 3 H), 1.42 - 1.52 (m, 3 H), 1.26 - 1.36 (m, 1 H), 1.19 - 1.26 
(m, 1 H), 1.14 - 1.19 (m, 6 H); 13C NMR (101 MHz, CDCl3) δ 168.6, 167.8, 
[1] For reviews, see; (a) K. V. Gothelf and K. A. Jørgensen, Chem. Rev. 
1998, 98, 863; (b) S. Kobayashi and K. A. Jørgensen, Cycloaddition 
Reactions in Organic Synthesis, Wiley-VCH Verlag GmbH, Weinheim, 
2001. 
[2] For reviews, see; (a) A. Padwa and W. H. Pearson, Synthetic 
Applications of 1,3-Dipolar Cycloaddition Chemistry Toward 
Heterocycles and Natural Products, John Wiley & Sons, Inc., New York, 
2003; (b) L. M. Stanley and M. P. Sibi, Chem. Rev. 2008, 108, 2887. 
147.5, 127.6, 122.0, 101.6, 76.4, 62.2, 61.2, 48.0, 40.6, 33.7, 29.3, 27.6, 
25.5, 22.5, 14.0, 13.7; HRMS m/z 425.1607 (calcd for C21H28ClNO6, 
425.1605). 
Compound 11d: The title compound was prepared according to the 
general Yb(OTf)3 catalyzed cycloaddition procedure for 15 minutes to 
afford a yellow oil (29 mg, 21%); Rf 0.40 (70% hexanes /EtOAc); 1H NMR 
(600 MHz, CDCl3) δ 7.16 – 7.24 (m, 4 H), 6.99 – 7.03 (m, 1 H), 5.03 (dd, J 
= 7.9, 3.8 Hz, 1 H), 4.19 – 4.25 (m, 2 H), 4.11 – 4.19 (m, 2 H), 3.94 (dq, J 
= 9.9, 7.1 Hz, 1 H), 3.61 (dq, J = 9.9, 7.1 Hz, 1 H), 2.58 (dt, 13.5, 4.7 Hz, 
1 H), 2.44 (ddd, 13.4, 12.2, 4.4 Hz, 1 H), 1.97 (dq, J = 13.4, 4.2 Hz, 1 H), 
1.76 – 1.84 (m, 1 H), 1.22 (t, J = 7.0 Hz, 3 H), 1.18 (t, J = 7.0 Hz, 3 H), 1.13 
(t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, CDCl3) δ 168.4, 168.1, 148.3, 
127.7, 123.3, 119.5, 102.5, 74.8, 64.7, 61.9, 61.6, 30.8, 27.0, 15.1, 13.8, 
13.7; HRMS m/z 351.1679 (calcd for C18H25NO6, 351.1682). 
Compound 12a: The title compound was prepared according to the 
general MgI2 catalyzed cycloaddition procedure at 0 °C for 15 minutes to 
afford a yellow oil (43 mg, 38%); Rf 0.36 (70% hexanes /EtOAc); 1H NMR 
(600 MHz, CDCl3) δ 7.19 – 7.23 (m, 2 H), 6.75 – 6.79 (m, 2 H), 5.00 (dd, J 
= 8.2, 3.5 Hz, 1 H), 4.06 – 4.23 (m, 4 H), 3.83 – 3.90 (m, 1 H), 3.77 (s, 3 
H), 3.53 – 3.60 (m, 1 H), 2.57 (dt, J = 13.5, 4.7 Hz, 1 H), 2.44 (td, J = 12.6, 
4.7 Hz, 1 H), 1.95 (dq, J = 13.4, 4.2 Hz, 1 H), 1.73 – 1.83 (m, 1 H), 1.17 – 
1.22 (m, 6 H), 1.13 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, CDCl3) δ 168.3, 
168.1, 156.4, 141.3, 122.7, 112.8, 102.3, 75.2, 64.6, 61.8, 61.5, 55.4, 27.1, 
37.7, 15.1, 13.9, 13.8; HRMS m/z 381.1778 (calcd for C19H27NO7, 
381.1788). 
Compound 14a: To a stirred solution of MgI2 (47 mg, 0.17 mmol) in 6 mL 
CH2Cl2 at room temperature was added 12a (130 mg, 0.34 mmol). The 
reaction mixture was stirred for about 30 minutes at room temperature 
(complete consumption of starting material by TLC) then the reaction 
mixture was layered directly onto a silica gel column and purified by flash 
chromatography (0-25% EtOAc/hexanes) to afford a yellow oil (50 mg, 
38%); Rf 0.43 (70% hexanes /EtOAc); 1H NMR (400 MHz, CDCl3) δ 6.70 - 
6.75 (m, 2 H), 6.58 - 6.64 (m, 2 H), 4.81 (s, 1 H), 4.16 - 4.26 (m, 4 H), 4.04 
(q, J = 7.2 Hz, 2 H), 3.73 (s, 3 H), 2.61 - 2.68 (m, 2 H), 2.22 - 2.29 (m, 2 
H), 1.19 (t, J = 7.0 Hz, 9 H); 13C NMR (101 MHz, CDCl3) δ 196.3, 172.7, 
169.6, 153.2, 137.6, 116.9, 114.6, 68.1, 62.4, 60.5, 55.6, 28.7, 27.4, 14.1, 
13.9; HRMS m/z 381.1789 (calcd for C19H27NO7, 381.1788). 
Acknowledgements 
We thank the University of Western Ontario and the Natural 
Sciences and Engineering Research Council of Canada for financial 
support. We also thank Ms. Aneta Borecki for X-ray crystallographic 
analysis, Dr. Mathew Willans for NMR spectrographic assistance, Mr. 
Doug Hairsine for high resolution mass spectroscopy, Prof. Michael A. 
Kerr and Dr. Andrew C. Stevens for helpful discussions (all from 
UWO). 
[3] For reviews, see; (a) T. Seiser, T. Saget, D. N. Tran and N. Cramer, 
Angew. Chem. Int. Ed. 2011, 50, 7740; (b) J. I. Matsuo, Tetrahedron Lett. 
2014, 55, 2589; (c) F. de Nanteuil, F. De Simone, R. Frei, F. Benfatt, E. 
Serrano and J. Waser, Chem. Commun. 2014, 50, 10912; (d) H.-U. 
Reissig and R. Zimmer, Angew. Chem. Int. Ed. 2015, 54, 5009.  
[4]  For examples see; (a) S. Shimada, K. Saigo, H. Nakamura and M. 
Hasegawa, Chem. Lett. 1991, 20, 1149; (b) E. A. Allart, S. D. R. Christie, 
G. J. Pritchard and M. R. J. Elsegood, Chem. Commun. 2009, 7339; (c) 
A. T. Parsons and J. S. Johnson, J. Am. Chem. Soc. 2009, 131, 14202; 
                                                 
FULL PAPER          
 
 
 
 
                                                                                                                                                                        
(d) M. M. A. R. Moustafa and B. L. Pagenkopf, Org. Lett. 2010, 12, 4732; (e) M. M. A. R. Moustafa, A. C. Stevens, B. P. Machin and B. L. Pagenkopf, Org. 
Lett. 2010, 12, 4736; (f) B. P. Machin and B. L. Pagenkopf, Synlett 2011, 2799; (g) A. C. Stevens, C. Palmer and B. L. Pagenkopf, Org. Lett. 2011, 13, 1528; 
(h) F. de Nanteuil and J. Waser, Angew. Chem. Int. Ed. 2013, 52, 9009; (i) R. Shenje, M. C. Martin and S. France, Angew. Chem. Int. Ed. 2014, 53, 13907. 
(j) D. Perrotta, S. Racine, J. Vuilleumier, F. de Nanteuil, J. Waser, Org. Lett. 2015, 17, 1030. 
[5] For examples, see; (a) J.-i. Matsuo, S. Sasaki, H. Tanaka and H. Ishibashi, J. Am. Chem. Soc. 2008, 130, 11600; (b) J.-i. Matsuo, S. Sasaki, T. Hoshikawa 
and H. Ishibashi, Org. Lett. 2009, 11, 3822; (c) J.-i. Matsuo, S. Negishi and H. Ishibashi, Tetrahedron Lett. 2009, 50, 5831; (d) J.-i. Matsuo, S. Sasaki, T. 
Hoshikawa and H. Ishibashi, Chem. Commun. 2010, 46, 934; (e) S. Negishi, H. Ishibashi and J.-i. Matsuo, Org. Lett. 2010, 12, 4984; (f) J.-i. Matsuo, R. 
Okado and H. Ishibashi, Org. Lett. 2010, 12, 3266; (g) M. Kawano, T. Kiuchi, S. Negishi, H. Tanaka, T. Hoshikawa, J.-i. Matsuo and H. Ishibashi, Angew. 
Chem. Int. Ed. 2013, 52, 906; (h) L. Souillart and N. Cramer, Chem. Eur. J. 2015, 21, 1863. 
[6]  N. Vemula, A. C. Stevens, T. B. Schon and B. L. Pagenkopf, Chem. Commun. 2014, 50, 1668. 
[7]  See experimental section for complete list of catalyst screening. 
[8]  See experimental section for complete optimization study. 
[9] CCDC 1061592 contains the crystal data for 7c. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk. 
[10]  No conversion to 5c was observed when 4c was exposed to 50 mol % MgI2. 
[11] CCDC 1061593 contains the crystal data for 9a. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk. 
[12]  W. L. F. Armarego, D. D. Perrin, Purification of Laboratory Chemicals; 4th Ed.; Oxford; Boston: Butterworth Heinemann, 1996. 
[13] See footnote 50 in: Y. Gao, R. M. Hanson, J. M. Klunder, S. Y. Ko, H. Masamune, K. B. Sharpless, J. Am. Chem. Soc. 1987, 109, 5765. 
[14]  W. C. Still, M. Kahn, A. Mitra, J. Org. Chem. 1978, 43, 2923. 
[15]  (a) E. C. Taylor, C.P. Tseng, J. B. Rampal. J. Org. Chem. 1982, 47, 552; (b) B. Priewisch, K. Rück-Braun, J. Org. Chem. 2005, 70, 2350; (c) A. Defoin, 
Synthesis 2008, 760. (d) G. A. Molander and L. N. Cavalcanti, J. Org. Chem. 2012, 77 , 4402. 
FULL PAPER          
 
 
 
 
 
FULL PAPER 
 
During efforts to expand the scope of Lewis acid catalyzed [4+2] cycloaddition 
between donor-acceptor cyclobutanes and nitrosoarenes, an unexpected 
formation of pyrrolidine products was discovered when 50 mol % of MgI2 was 
used as a Lewis acid. It was also observed that the electronics of the 
nitrosoarene and judicious selection of the Lewis acid catalyst have a profound 
effect on the regioselectivity of the reaction. 
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